Editing of human alpha-galactosidase RNA resulting in a pyrimidine to purine conversion

Nucleic Acids Res. 1995 Jul 25;23(14):2636-40. doi: 10.1093/nar/23.14.2636.

Abstract

During a study of the gene coding for alpha-galactosidase (EC 3.2.1.22), the lysosomal enzyme deficient in Fabry's disease, RT-PCR amplification of alpha-galactosidase mRNAs obtained from three different tissues isolated from males revealed a substantial number of clones with a U to A conversion at the nucleotide position 1187. Such a modification of the coding sequence would result in an amino acid substitution in the C-terminal region (Phe396Tyr) of the enzyme. Neither PCR analysis of the genomic sequence nor the RT-PCR amplification of RNA obtained by in vitro transcription of the wild-type cDNA showed this change in the sequence. Multiple genes, pseudogenes are allelic variants were excluded. Hence, we propose RNA editing as a mechanism responsible for this base change in the alpha-galactosidase RNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • DNA Primers / genetics
  • DNA, Complementary / chemistry
  • DNA, Complementary / genetics
  • Deoxyribonucleases, Type II Site-Specific
  • Humans
  • Male
  • Molecular Sequence Data
  • Nucleic Acid Conformation
  • Polymerase Chain Reaction
  • RNA Editing / genetics*
  • alpha-Galactosidase / genetics*

Substances

  • DNA Primers
  • DNA, Complementary
  • Deoxyribonucleases, Type II Site-Specific
  • GTAC-specific type II deoxyribonucleases
  • alpha-Galactosidase